Adapthealth Corp. · NASDAQ:AHCO
Adapthealth — Q4 2022 Earnings Presentation
10 slides from Adapthealth's earnings presentation, Feb 1, 2023
Slide 1: Financial Supplement Q4 2022
Financial Supplement Q4 2022
Slide 2: Disclaimer
Disclaimer This presentation contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management's current views concerning future business, events, trends, contingencies, financial performance, or financial condition,
Slide 3: Summary Financial Results
Summary Financial Results (in thousands) Three Months Ended December 31, September 30, June 30, March 31, December 31, 2022 2022 2022 2022 2021 Sales revenue $ 534,548 $ 512,523 $ 492,654 $ 475,955 $ 489,373 Rental revenue $ 245,735 $ 243,972 $ 234,960 $ 230,248 $ 212,733 Total net revenue $ 780,283
Slide 4: Q4 2022 Business Mix Summary
Q4 2022 Business Mix Summary Other 8.1% Patient Pay 11.4% Rental Sleep 31.5% Diabetes 36.6% 24.6% Government Resupply Sale 26.3% Insurance 59.4% 62.3% One-time Sale Supplies to 9.1% the home 6.1% Respiratory HME 7.0% 17.6% ~91% of revenue comes from recurring sales or rentals Sale Type Product Payor
Slide 5: Revenue by Product
Revenue by Product (in thousands) Three Months Ended December 31, September 30, June 30, March 31, December 31, 2022 2022 2022 2022 2021 Net sales revenue Sleep $ 208,787 $ 198,206 $ 194,693 $ 192,335 $ 188,758 Diabetes 188,295 169,075 162,259 151,359 175,523 Supplies to the home 47,787 47,793 43,88
Slide 6: Net Revenue Growth
Net Revenue Growth In millions Reported Net Revenue Growth Non-Acquired Net Revenue Growth (1) +11.1% +5.3% 6.1% ~$780 ~$722 ~$686 ~$702 5.3% $0 3.7% 3.5% 702 Q4’21 Q4’22 Q4’21 Non- Q4’22 Non- -0.3% Reported Reported Acquired Acquired B2B Q1’22 Q2’22 Q3’22 Q4’22 FY22 (1) Non-Acquired net revenue com
Slide 7: Appendix
Appendix
Slide 8: Non-GAAP Reconciliation
Non-GAAP Reconciliation (in thousands) Three Months Ended Twelve Months Ended December 31, December 31, December 31, December 31, 2022 2021 2022 2021 Net (loss) income attributable to AdaptHealth Corp. $ (2,588) $ 22,942 $ 69,316 $ 156,175 Income attributable to noncontrolling interests 1,017 529 3,
Slide 9: Share Count Information
Share Count Information Total Common and Preferred Stock if (in thousands) Common Stock Preferred Stock (1) Converted Number of shares outstanding, September 30, 2022 134,723 124 147,129 Equity-based compensation activity 168 - 168 Exercise of stock options and warrants 295 - 295 Shares purchased un
Slide 10: Earnings Per Share
Earnings Per Share Three Months Ended December 31, Twelve Months Ended December 31, 2022 2021 2022 2021 Numerator Net (loss) income attributable to AdaptHealth Corp. $ (2,588) $ 22,942 $ 69,316 $ 156,175 Less: Earnings allocated to participating securities (1) — 1,965 5,867 14,379 Net (loss) income